New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

Updated on: January 11,2024

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

Updated on:January 11,2024

In preclinical studies, team identifies potential therapy for metastatic colon cancer

by Weill Cornell Medical CollegeMultiplex immunofluorescence image of hyaluronan-rich human colorectal cancer. Highly aggressive tumoral cells (turquoise and magenta) are negative for both aPKCs

Updated on: February 24,2024

In preclinical studies, team identifies potential therapy for metastatic colon cancer

by Weill Cornell Medical CollegeMultiplex immunofluorescence image of hyaluronan-rich human colorectal cancer. Highly aggressive tumoral cells (turquoise and magenta) are negative for both aPKCs

Updated on:February 24,2024

Colorectal cancer gene implicated in broad range of solid tumors

by Amy Mone, Valerie Mehl,Johns Hopkins UniversityMUTYH-altered samples. (A) CONSORT diagram showing grouping of samples. Samples with somatic MUTYH alterations including pathogenic short varian

Updated on: March 27,2024

Colorectal cancer gene implicated in broad range of solid tumors

by Amy Mone, Valerie Mehl,Johns Hopkins UniversityMUTYH-altered samples. (A) CONSORT diagram showing grouping of samples. Samples with somatic MUTYH alterations including pathogenic short varian

Updated on:March 27,2024

Updated colorectal cancer screening effective for adults 45–50, study suggests

byKaiser PermanenteCredit: Pixabay/CC0 Public DomainThe updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults

Updated on: November 09,2024

Updated colorectal cancer screening effective for adults 45–50, study suggests

byKaiser PermanenteCredit: Pixabay/CC0 Public DomainThe updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults

Updated on:November 09,2024

As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

by Carla K. JohnsonJill Feldman, 54, poses for a photo at her home in Deerfield, Ill., Friday, Jan. 19, 2024. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by bl

Updated on: June 25,2024

As cancer treatment advances, patients and doctors push back against drugs' harsh side effects

by Carla K. JohnsonJill Feldman, 54, poses for a photo at her home in Deerfield, Ill., Friday, Jan. 19, 2024. Lung cancer patient and advocate Jill Feldman takes pills at home that shrink tumors by bl

Updated on:June 25,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on: January 26,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on:January 26,2024

Exploring the role of reactive oxygen species in cellular health and disease through HyPerion

Updated on: July 17,2024

Exploring the role of reactive oxygen species in cellular health and disease through HyPerion

Updated on:July 17,2024

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece

Updated on: December 25,2023

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece

Updated on:December 25,2023

World-first clinical trial with 'man's best friend' could unlock treatment breakthrough for kids with cancer

by Telethon Kids InstituteThree-year-old Bull Terrier, Maggie, is about to undergo surgery using the immunotherapy gel to treat her sarcoma. It is hoped the world-first clinical trial in dogs will be

Updated on: January 04,2024

World-first clinical trial with 'man's best friend' could unlock treatment breakthrough for kids with cancer

by Telethon Kids InstituteThree-year-old Bull Terrier, Maggie, is about to undergo surgery using the immunotherapy gel to treat her sarcoma. It is hoped the world-first clinical trial in dogs will be

Updated on:January 04,2024

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Updated on: January 07,2024

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Updated on:January 07,2024

Cancer cases will keep rising worldwide: Report

by Dennis ThompsonCancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows.An estimated 20 million new cancer cases were diagnosed

Updated on: April 06,2024

Cancer cases will keep rising worldwide: Report

by Dennis ThompsonCancer cases will continue to climb for the next two decades, spurred on by an aging worldwide population, a new report shows.An estimated 20 million new cancer cases were diagnosed

Updated on:April 06,2024

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Updated on: August 27,2024

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Updated on:August 27,2024